...
首页> 外文期刊>Leukemia and lymphoma >Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: a case-control study.
【24h】

Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: a case-control study.

机译:甲状腺疾病和甲状腺自身免疫性疾病与多发性骨髓瘤风险的关联:病例对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Thyroid disease has been associated with lymphohematopoietic cancer (LHC). No previous study using clinical, sonographic and laboratory data has explored whether thyroid disease and specifically autoimmune thyroid disease (ATD) is associated with multiple myeloma (MM) risk. 73 patients with incident primary MM and 73 hospital controls admitted for non-neoplastic and non-infectious conditions, matched on gender and age were studied between 2001 and 2007. Blood samples were collected. All subjects were submitted to clinical, ultrasound and laboratory thyroid evaluation. The prevalence of clinical thyroid disease in MM patients was significantly higher than in controls (p = 0.002). ATD was associated with increased risk of MM, adjusting for age, gender, body mass index and familial history of LHC [OR = 5.68, 95% confidence interval (CI): 1.69-19.13]. Controlling for the above variables, an individual suffering from any thyroid disease more than 10 years has about 2.41 times more likely the risk to developMM than an individual without any thyroid disease (OR = 2.41, 95% CI: 1.35-4.29). Also, adjusting for age, gender, BMI and family history of LHC, a familial history of thyroid disease is associated with increased risk of MM (OR = 3.23, 95% CI: 1.25-8.31). Further studies are needed to explore underlying mechanisms associating thyroid autoimmunity with plasma cell transformation.
机译:甲状腺疾病与淋巴造血癌(LHC)有关。以前没有使用临床,超声检查和实验室数据进行的研究来探讨甲状腺疾病,尤其是自身免疫性甲状腺疾病(ATD)是否与多发性骨髓瘤(MM)风险相关。在2001年至2007年之间,对73例原发性MM患者和73例因非肿瘤和非感染性疾病而入院的住院患者进行了性别和年龄匹配研究。收集了血液样本。所有受试者均接受临床,超声和实验室甲状腺评估。 MM患者的临床甲状腺疾病患病率显着高于对照组(p = 0.002)。 ATD与MM风险增加有关,需要调整年龄,性别,体重指数和LHC家族史[OR = 5.68,95%置信区间(CI):1.69-19.13]。通过控制上述变量,患有任何甲状腺疾病超过10年的个体患MM的可能性比没有甲状腺疾病的个体高2.41倍(OR = 2.41,95%CI:1.35-4.29)。同样,根据年龄,性别,BMI和LHC家族史进行调整后,甲状腺疾病的家族史与MM风险增加相关(OR = 3.23,95%CI:1.25-8.31)。需要进一步的研究来探索将甲状腺自身免疫与浆细胞转化相关的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号